$INSY This morning's Press Release is an open and
Post# of 212
(Total Views: 246)
Posted On: 11/02/2017 10:32:42 AM
$INSY This morning's Press Release is an open and honest critique of the status of Insys Therapeutics, Inc. Well worth reading and digesting the words.
The company acknowledges that it is in a difficult position and presents a snippet of the good, bad, and ugly that it anticipates to occur over the coming months. Reserve dollars remain good. Sales and profits are down slightly but should rebound. Inventory/returns are not as positive as in the past. The Federal and State Court Cases will continue.
The Crisis Control by INSYS is outstanding. The products should remain profitable and viable, this is the understanding behind the latest Press Release. As long as investors believe that the Executive Management of INSYS is open and honest with the public and has taken measures to correct past mistakes, this company WILL turn-around. The share price will still take time to return to the higher dollar levels it enjoyed for many months. How EXECUTIVE MANAGEMENT continues to respond to the public will be the driving force behind the increase in share price. So far, they have done EVERYTHING right.
The company acknowledges that it is in a difficult position and presents a snippet of the good, bad, and ugly that it anticipates to occur over the coming months. Reserve dollars remain good. Sales and profits are down slightly but should rebound. Inventory/returns are not as positive as in the past. The Federal and State Court Cases will continue.
The Crisis Control by INSYS is outstanding. The products should remain profitable and viable, this is the understanding behind the latest Press Release. As long as investors believe that the Executive Management of INSYS is open and honest with the public and has taken measures to correct past mistakes, this company WILL turn-around. The share price will still take time to return to the higher dollar levels it enjoyed for many months. How EXECUTIVE MANAGEMENT continues to respond to the public will be the driving force behind the increase in share price. So far, they have done EVERYTHING right.
(0)
(0)Insys Therapeutics Inc. (INSYQ) Stock Research Links
Scroll down for more posts ▼